Lopinavir hydrate is the hydrated form of lopinavir, a protease inhibitor used mainly in combination with ritonavir to treat HIV-1 infections. It works by inhibiting the HIV-1 protease enzyme, that is essential for viral replication. Ritonavir boosts lopinavir’s effectiveness by slowing its metabolism via CYP3A inhibition, allowing higher plasma concentrations of lopinavir. Its therapeutic use is listed as antivirals. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Lopinavir hydrate and Lopinavir water adduct. Its PubChem CID is 66766312.
Lopinavir monohydrate
| CAS No | 1239071-09-0 |
|---|---|
| Molecular Formula | C37H50N4O6 |
| Molecular Weight | 646.80 g/mol |
| Synonyms | (2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide;hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lopinavir hydrate is the hydrated form of lopinavir, a protease inhibitor used mainly in combination with ritonavir to treat HIV-1 infections. It works by inhibiting the HIV-1 protease enzyme, that is essential for viral replication.
The listed CAS number is 1239071-09-0.
The listed molecular formula is C37H50N4O6.
The listed molecular weight is 646.80 g/mol.
(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide;hydrate.
The source lists Lopinavir hydrate and Lopinavir water adduct.